[PDF] Top 20 A CASE REPORT ON THE BENIGN PROSTATIC HYPERPLASIA
Has 10000 "A CASE REPORT ON THE BENIGN PROSTATIC HYPERPLASIA" found on our website. Below are the top 20 most common "A CASE REPORT ON THE BENIGN PROSTATIC HYPERPLASIA".
A CASE REPORT ON THE BENIGN PROSTATIC HYPERPLASIA
... Ayurvedic drugs like snehan with Narayan tail, swedan with Dashmoola Kwath, Gokhuradi Guggulu, Varunshigru Kasaya,Basti therapy with luke warm Narayan tail along with madhu and shaindhav lavana(Anuvasan Basti) and ... See full document
5
MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY
... (O’Connor et al.) explained 23 cases that medically treated for BPH by combined therapy in the form of (alpha-blocker plus finasteride) after removal of bladder stone. They located decrease in IPSS in about 48.6% and ... See full document
5
Indications for Caesarean Section Among the Antenatal Cases Admitted In a Tertiary Care Hospital of Kollam, Kerala
... for Benign Prostatic Hyperplasia (BPH) Nodularity is the hallmark of Benign Prostatic ...usual case prostate enlarges up to 100gm and nodular hyperplasia of the prostate ... See full document
5
Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
... left prostatic arteries was completed when slow flow or stasis was observed, with disruption of arterial flow and opacification of the prostate ...right prostatic arteries were embolized in the same way as ... See full document
6
Intracapsular Prostatic Omentalization: A New Technique for Management of Prostatic Abscess in Dogs: Case Report
... hand benign as prostatic hyperplasia and on the other hand serious, cysts, abscesses and more rare prostatic ...these prostatic conditions, in order to better detect and offer the best ... See full document
5
Biomorphometric studies in benign prostatic hyperplasia
... Although benign prostatic hyperplasia (BPH) is the most common benign proliferative abnormality in men, knowledge of the epidemiology of BPH remains fragmentary and re quires more ...single ... See full document
303
Dysuria due to benign prostatic hyperplasia of the median lobe with ketamine-associated uropathy in a young male
... Ketamine-induced upper urinary tract lesions seem not to be paid enough attention due to a greater inci- dence of apparent lower urinary tract syndromes [16]. Hydronephrosis and ureteral wall thickening were re- ported ... See full document
6
DIFFEREN TIATION BETWEEN PROSTATIC' C A RCINOMA A ND BENIGN PROSTATIC HYPERPLASIA BY AgNOR STAINING
... One report has shown a decrease in the AgNOR number in prostatic cancer of experimental animals after ...in prostatic adenocarcinoma were much greater than prostatic hyperplasia ... See full document
6
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
... The report suggested that significant changes were observed at the earliest postbaseline assessments. IPSS, including storage and voiding subscores, improved signifi- cantly (P , 0.0005) within 3–4 days. Moreover, ... See full document
12
Relationship between Benign Prostatic Hyperplasia and International Prostatic Symptom Score
... It is suggested by numerous studies that IPSS can be used for the interpretation of symptoms of BPH. Recently a study conducted in the Shanghai population [1] found that Transitional zone volume and length in BPH ... See full document
9
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
... not report a significant benefit, one long-term study revealed significant advantages with combination therapy with alpha-blockers to prevent BPH progression events such as acute urinary retention and need for ... See full document
11
Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study
... into benign prostatic hyperplasia and normal groups, the benign prostatic hyperplasia group was then divided into prostate volume ≤ 60 g and > 60 g subgroups; all their ... See full document
8
Original Article Evaluation of glycophenotype in prostatic neoplasm by chemiluminescent assay
... Abstract: This work aimed to evaluate the glycophenotype in normal prostate, bening prostatic hyperplasia (BPH) and prostatic adenocarcinoma (PCa) tissues by a chemiluminescent method. Concanavalin A ... See full document
9
INFLAMMATION, HORMONE IMBALANCE: A PREDISPOSING FACTORS OF BENIGN PROSTATIC HYPERPLASIA: GENERAL REVIEW
... Benign prostatic hyperplasia (BPH) continues to be a significant healthcare problem ...fact prostatic inflammation may represent an important factor in influencing prostatic growth and ... See full document
9
Diagnosis and management of benign prostatic hyperplasia in primary care
... Benign prostatic hyperplasia (BPH), and its clinical manifestation as lower uri- nary tract symptoms (LUTS), is a major health concern for aging ... See full document
9
2010 Update: Guidelines for the management of benign prostatic hyperplasia
... These guidelines are directed toward the typical male patient over 50 years of age, presenting with lower urin- ary tract symptoms (LUTS) believed to be associated with benign prostatic obstruction (BPO). ... See full document
7
Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
... of prostatic cells into antigen-presenting cells, and up-regulation of growth factors (andromedins), lead- ing to prostate ...with prostatic volume and severity of ... See full document
7
AN AYURVEDIC APPROACH IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA .......
... mechanical or functional. Aim and To suggest an ayurvedic treatment modality in BPH and assessing it with ultrasonographic assistance in phase by phase estimation of the proposed clinical study for BPH studies ... See full document
7
Comparative study between transurethral resection (TURP) and transurethral incision (TUIP) of the prostate for small size benign prostatic hyperplasia.
... 55 Prostatic growth even in declining androgen levels suggests that other factors from the testis can stimulate prostate growth or sensitize prostatic cells to the effect of ...to prostatic ... See full document
91
Management of benign prostatic hyperplasia with silodosin
... of this drug at the clinical doses should be due to α 1A -AR blockade, suggesting that α 1A -AR is the predominant subtype involved in detrusor overactivity in BPH. One of the reasons that α 1A -AR antagonists improve ... See full document
7
Related subjects